Huons Meditech showcases Dermashine, shockwave lithotriptor at MEDICA 2025

Huons Meditech, a subsidiary of Huons Group, highlighted its flagship medical and aesthetic devices at MEDICA 2025, one of the world’s largest medical technology exhibitions, held Nov. 17-20 in Düsseldorf, Germany.

The company said Thursday it used the event to expand its global business network across Europe, the Middle East and Asia, while promoting its expanding portfolio of dermatology, urology and endoscopy products.

At the exhibition, Huons Meditech showcased its Dermashine lineup, including the Dermashine Pro and Dermashine Balance. The aesthetic injection system has sold more than 20,000 units globally and in August became the first electrically powered drug-delivery device developed in Korea to receive certification under Europe’s Medical Device Regulation. The company has since run campaigns emphasizing the importance of using certified needles and original components.

Also drawing attention was the URO-UEMXD, an extracorporeal shockwave lithotriptor that integrates a shockwave head and ultrasound in a straight in-line configuration. Huons Meditech says it is the first Korean-made system to adopt the dual-head structure, which improves stone localization compared with conventional X-ray guidance. The company also displayed the HUEN DR-02 endoscope reprocessor.